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Abstract: Following infection of exposed peripheral tissues, neurotropic alphaherpesviruses 
invade nerve endings and deposit their DNA genomes into the nuclei of neurons resident in 
ganglia  of  the  peripheral  nervous  system.  The  end  result  of  these  events  is  the 
establishment of a life-long latent infection. Neuroinvasion typically requires efficient viral 
transmission through a polarized epithelium followed by long-distance transport through 
the  viscous  axoplasm.  These  events  are  mediated  by  the  recruitment  of  the  cellular 
microtubule  motor  proteins  to  the  intracellular  viral  particle  and  by  alterations  to  the 
cytoskeletal architecture. The focus of this review is the interplay between neurotropic 
herpesviruses and the cytoskeleton. 
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1. Introduction 
Herpesviruses  are  widespread  in  nature  and  infect  a  broad  range  of  host  species  including 
vertebrates (mammals, birds, fish, reptiles) and invertebrates (mollusks, corals) [1–4]. Collectively, 
these viruses are categorized as the Herpesvirales order, with all members sharing several structural 
characteristics:  (1)  a  linear  double-stranded  DNA  genome  that  is  typically  100  kbp  or  larger;  
(2) a T = 16 icosahedral capsid consisting of 162 capsomers (150 hexons, 11 pentons and one portal 
vertex);  (3)  an  amorphous  layer  of  tegument  proteins  that  surrounds  the  capsid;  (4)  an  envelope 
consisting  of  a  lipid  bilayer  and  membrane-bound  proteins.  The  Herpesvirales  are  highly  diverse 
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genetically, with the most conserved protein being an ATPase that participates in packaging of viral 
genomes into capsids [5].  
There are also similarities in key aspects of the infectious cycle, which include: (1) entry into the 
cell  via  receptor-mediated  fusion,  (2)  delivery  of  the  encapsidated  genome  to  the  nucleus,  
(3) establishment of life-long latent infection, (4) DNA replication and capsid assembly inside the 
nucleus,  (5)  exit  of  encapsidated  genomes  from  the  nucleus  to  the  cytosol,  (6)  maturation  and 
envelopment of viral particles in the cytoplasm, and (7) exocytosis of infectious viral particles. 
The importance of interactions between viruses and the host cytoskeleton is well established in 
cultured systems [6–10]. However, the mechanism of certain viral-induced cytoskeletal changes and 
the benefit they convey to the replicating virus remain unclear. Moreover, differences between culture 
models of infection and how cytoskeletal interactions impact infection in animal hosts need to be 
addressed. This review summarizes our current knowledge of alphaherpesvirus engagement of the host 
cytoskeleton and discusses the implications of these processes to neuroinvasion. 
1.1. The Alphaherpesvirinae 
Although all herpesviruses share several important biological characteristics, they vary largely in 
host range, tissue tropism, replication kinetics, clinical symptoms and disease severity [11,12]. There 
are three families within the Herpesvirales order of which one, the Herpesviridae, includes known 
pathogens of mammals. The Herpesviridae is further divided into three subfamilies named the Alpha-, 
Beta- and Gammaherpesvirinae [13–15]. The neuroinvasive herpesviruses, which are the subject of 
this review, are members of three of the four genera of Alphaherpesvirinae, two of which include 
mammalian and marsupial pathogens: the Simplexviruses and the Varicelloviruses (Figure 1) [13]. The 
term ―neuroinvasion‖ can have differing applications: in this review we apply the term to refer to 
invasion of neurons that were not directly exposed to inoculation (i.e., spread from non-neuronal tissue 
to neurons), however, the term may also specifically refer to invasion of neurons resident in the central 
nervous system (i.e., encephalitic infections). 
Figure 1. Taxonomy of neuroinvasive herpesviruses. Neuroinvasive herpesviruses include 
species from three genera of the Alphaherpesvirinae subfamily. Virus species mentioned in 
this review are as follows: herpes simplex virus type 1  (HSV-1) and type 2 (HSV-2); 
monkey B virus (B-virus); varicella-zoster virus (VZV); pseudorabies virus (PRV); bovine 
herpesvirus type 1 (BHV-1); equine herpesvirus type 1 (EHV-1). 
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A  common  characteristic  of  the  Alphaherpesvirinae  is  a  rapid  reproductive  cycle,  followed  by 
destruction of the host cell in a wide variety of susceptible tissues [16]. Although infections are often 
not associated with evident symptoms, severe disease (for example encephalitis and meningitis) can 
arise from the active replication of these viruses coupled with their propensity to spread within neural 
circuits. This is in contrast to the lymphotropic Gammaherpesvirinae which, in general, produce severe 
disease  (for  example  lymphomas  and  sarcomas)  as  a  consequence  of  latency  [17].  The  prototype 
member of the Simplexvirus genus is Human herpesvirus 1 (herpes simplex type 1; HSV-1). Other 
human  pathogens  in  this  family  are  Human  herpesvirus  2  (herpes  simplex  type  2;  HSV-2)  and 
Cercopithecine herpesvirus 1 (B-virus). Although the latter virus is not endemic in humans, zoonotic 
spread can result in lethal infections [18]. The prototype member of the Varicellovirus genus is Human 
herpes virus 3 (varicella-zoster virus; VZV), which is the causative agent of chickenpox and shingles. 
This  genus  also  encompasses  a  number  of  veterinary  pathogens,  including  Suid  herpesvirus  1 
(pseudorabies virus; PRV), which is commonly used to model neuroinvasive infections both in vitro 
and  in  vivo.  The  remaining  two  genera,  Mardiviruses  and  Iltoviruses,  comprise  viruses  of  avian 
tropism that are classified as Alphaherpesvirinae primarily based on genetic conservation [13]. Like 
viruses  belonging  to  the  Gammaherpesvirinae  subfamily,  the  Mardiviruses  establish  latency  in  T 
lymphocytes and are noted for their oncogenicity [19]. Although Mardiviruses have not been detected 
in  neurons in  vivo, they infect explanted non-myelinated neurons  and surrounding Schwann cells. 
However, demyelination of peripheral axons is more likely caused by virus-induced T lymphocyte 
infiltration and not direct neuronal infection [20]. The Iltoviruses cause contagious respiratory disease. 
Chickens infected with the prototype of this genera, Gallid herpesvirus 1 (infectious laryngotracheitis 
virus;  ILTV),  test  positive  by  PCR  for  infection  of  the  trigeminal  ganglia.  The  virus  is  therefore 
considered neuroinvasive,  although  confirmation  of  infection  of  neurons  within the  ganglia  is  not 
available [21].  
1.2. Neuroinvasive Herpesvirus Disease 
HSV-1 and HSV-2 symptoms are usually restricted to epidermal lesions around the mouth (cold 
sores; herpes labialis) and genitals, respectively. Less frequently, HSV-1 infects the eye and produces 
keratitis, which is the leading cause of infectious blindness in the developed world [22]. Each of these 
forms of disease can reoccur due to the latent infection that is established in neurons of the peripheral 
ganglia  that  innervates  the  respective  tissues  (typically  the  trigeminal  ganglia  for  HSV-1  and  the 
lumbosacral dorsal root ganglia for HSV-2). Autonomic ganglia also may become infected [23,24]. 
Rarer  but  more  severe,  HSV-1  transmission  from  the  peripheral  nervous  system  to  the  brain  can 
produce  life-threatening  encephalitis.  Herpes  encephalitis  is  generally  sporadic  and  infrequent, 
although  there  is  evidence  for  genetic  predisposition  to  this  severe  form  of  disease  [25].  Herpes 
encephalitis is most frequent in neonates infected during birth and these infections can also produce 
multi-organ disseminated disease, both of which are associated with high mortality and morbidity [26]. 
Adults  with  compromised  immune  systems  (including  patients  with  AIDS,  cancer,  and  transplant 
patients) can suffer disseminated infections that become resistant to acyclovir [27,28]. 
Unlike the Simplexviruses, primary VZV infection (chicken pox; varicella) initially disseminates by 
cell-associated viremia following replication in lymph nodes. Subsequently, the virus expands after Viruses 2011, 3                         
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additional replication in the liver and spleen. Thus, VZV has broad tissue tropism that includes T-cells 
and monocytes. The infection subsequently transmits to the skin where virus-driven cell-cell fusion 
induces polykaryocyte formation and characteristic pox lesions [29]. At this stage of the infection, 
virions in the skin invade the sensory nervous system in a manner similar to  Simplexviruses, and 
establish latency in neurons of the dorsal root ganglia. Reactivation of VZV is usually infrequent and is 
often in a single dorsal root ganglion of an older individual, possibly due to waning immunity to the 
virus. Each dorsal root ganglion innervates a specific region of the skin (a dermatome), which defines 
the  presentation  area  and  size  of  the  resulting  painful  skin  lesions  (shingles;  zoster)  [30].  The 
symptoms of pain can persist long after the rash has receded in a manifestation termed postherpetic 
neuralgia. Like the Simplexviruses, neuroinvasion by VZV is usually confined to the PNS; spread to 
the  CNS  is  rare  but  severe.  VZV  infection  can  also  cause  life-threatening  diseases,  including 
encephalitis and pneumonia, in individuals with compromised immunity [31,32]. 
A wide assortment of neuroinvasive herpesviruses infects domestic and wild animals. Common 
presentations include skin lesions, respiratory disease, keratitis, abortion, pneumonia, and encephalitis 
[33–35]. Some of these viruses have a propensity to jump to secondary hosts, which typically result in 
lethal, dead-end  infections.  Unlike infections of natural  hosts, in  which  neuroinvasion is typically 
restricted to the peripheral nervous system, dead-end host infections spread to the brain by default. 
Perhaps the most striking example of this is PRV, which normally resides in pig populations  (the 
natural  host)  but  transmits  to  mammals  ranging  from  rodents  to  large  carnivores  [36].  Similarly,  
B-virus  transmission  to  humans  is  fatal  if  left  untreated  [37];  and  conversely,  marmosets  are 
susceptible  to  lethal  HSV-1  infections  [38].  Remarkably,  CNS  invasion  occurs  by  trans-synaptic 
transmission along neuronal circuits: these viruses are highly proficient at spreading between neurons 
across synaptic connections even though this attribute provides no clear selective advantage to these 
viruses [39,40]. 
2. Alphaherpesviruses and the Host Cell Cytoskeleton: Interactions and Virus-Induced Changes 
Alphaherpesviruses, like all viruses, are obligate intracellular parasites that depend on many aspects 
of the cell to propagate and ultimately maintain their presence in host populations. Gaining access to 
the resources of the cell requires specialized adaptation. Here we discuss a selection of tactics used by 
neuroinvasive  alphaherpesviruses  to  subvert  innate  cellular  transport  mechanisms  and  effect  viral 
replication and spread within cells and tissues. 
2.1. Cytoskeleton Organization of Polarized Epithelium and Sensory Neurons 
Neuroinvasive alphaherpesviruses initially replicate in epithelia and subsequently establish latency 
in  the  peripheral  nervous  system,  predominantly  in  pseudounipolar  neurons  resident  in  sensory 
ganglia. A morphological and functional hallmark of both epithelial cells and neurons is their polarity, 
and similarities between the establishment and function of the polarity in these two cell types have 
been  noted.  For  example,  proteins  that  sort  to  the  apical  membrane  of  epithelial  cells  often  sort 
specifically  to  axons  when  expressed  in  neurons  [41,42],  and  epithelial  adherence  junctions  and 
neuronal puncta adherentia junctions are likely related structures [43–45]. However, for the most part 
these  cells  are  unique,  with  differences  in  the  organization  and  maintenance  of  the  cytoskeletal Viruses 2011, 3                         
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network  defining  the  structural  and  functional  polarity  of  each  cell  type.  As  will  be  discussed, 
differences in cellular architectures present an obstacle for herpesviruses: polar cells require polar 
modes of viral  entry and egress that must  be  adjusted between epithelial and  neuronal cells.  The 
herpesvirus  infectious  cycle  is  achieved  by  recognizing  and  adjusting  to  different  intracellular 
environments.  Regulation  of  the  resulting  life-long  infection  in  stages  of  productive  and  latent 
infection  adds  further  complexity  to  the  infectious  cycle  to  restrict  pathogenesis  and  maximize 
dissemination in host populations. This is an impressive feat that helps explain why the majority of the 
world’s population is infected by these viruses, with one critical element of this success arising from 
the interactions between these neuroinvasive viruses and the cellular cytoskeleton.  
The cytoskeleton is a dynamic assembly of structures that facilitates changes in cell shape, cell 
locomotion,  chromosomal  segregation,  cell  division,  and  intracellular  trafficking  of  molecular 
complexes  and  organelles  [46,47].  The  cytoskeleton  of  mammalian  cells  consists  of  three  main 
components: actin, tubulin and intermediate filaments. Each of these exists in a dynamic equilibrium 
between monomeric and filamentous forms. Although detailed descriptions of the biology of each of 
these cytoskeletal elements are widely available, we will next present brief overviews of the F-actin 
and microtubule cytoskeletal components found in epithelial and neuronal cells with an emphasis of 
those features most relevant to the subsequent discussion of neuroinvasive herpesvirus infection. 
2.1.1. Actin 
The  actin  monomer  is  an  ATPase,  with  ATP  hydrolysis  driving  the  dynamic  balance  between 
monomeric G-actin (globular) and filamentous F-actin in the cell [48]. Actin filaments have a 7–8 nm 
diameter  and  are  intrinsically  polar,  with  the  barbed/plus  ends  often  associated  with  the  plasma 
membrane and exhibiting high turnover  [49]. In non-muscle cells, actin filaments build a densely 
branched mesh underneath the plasma membrane and provide the driving force for membrane ruffling, 
lamellipodia  and  filopodia  outgrowth,  and  macropinocytosis.  The  highly  dynamic  nature  of  actin 
filaments allows for rapid responses to extra- or intra-cellular cues [50]. In non-musculature cells, actin 
filaments  build  a  dense  mesh  underneath  the  plasma  membrane.  Regulation  of  these  dynamics  is 
achieved by an extensive array of actin-associated proteins including small GTPases [51–53], and by 
posttranslational modification of different actin isoforms including direct phosphorylation by PAK1 
(p21 protein (Cdc42/Rab)-activated kinases 1) [54,55].  
The polarized structure of epithelia is dependent upon actin. The apical section of an epithelial  
cell  contains  three  zones  of  actin  filaments  that  include:  filament  bundles  that  support  microvilli, 
filaments  connected  to  tight  junctions,  and  a  perijunctional  belt  of  actin  filaments  that  directly  
binds catenin/cadherin and afadin/nectin adhesion complexes [56,57]. This specific organization of 
actin  is  essential  for  establishment  and  maintenance  of  apical-basal  polarity  and  maintenance  of  
cell-cell adhesion.  
In neurons, polarity is established by actin dynamics that drive the outgrowth of axons within a 
lamellipodial structure called the growth cone [58]. Upon maturation, the axon growth cone is replaced 
by a specialized axon ending, which may consist of a presynaptic terminal that communicates with a 
muscle  cell  or  another  neuron  or  a  sensory  nerve  ending  such  as  those  in  the  skin  and  mucosa. 
Maintenance of neuronal polarity is primarily the purview of microtubules and intermediate filaments; Viruses 2011, 3                         
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however, actin continues to contribute to polarity by providing a selective barrier function within the 
axon hillock. The hillock forms the soma-axon junction and keeps the Golgi apparatus and lysosomes 
inside the cell body while allowing for the passage of mitochondria and pre-synaptic vesicles into the 
axon  [59].  Actin  also  plays  major  roles  in  the  morphogenesis  of  synapses,  including  presynaptic 
terminals,  post  synaptic  dendritic  spines,  and  puncta  adherentia  junctions  (PAJ)  that  strengthen 
synaptic connections through interactions between presynaptic nectin-1 and postsynaptic nectin-3 [51]. 
Synaptic  vesicle  endocytosis  and  exocytosis  at  presynaptic  terminals  is  also  modulated  by  actin 
dynamics [60].  
2.1.2. Tubulin and Microtubules 
Tubulin dimers assemble into 25 nm tubular structures called microtubules that provide a network 
for  long-distance  intracellular  transport  [61].  Similar  to  actin  filaments,  microtubules  are  polar 
structures with a dynamic plus end and a more stable minus end. Regulation of microtubule dynamics 
is  modulated  by  microtubule-associated  proteins  and  small  GTPases  [61].  Moreover,  tubulin  is 
posttranslationally modified in a number of ways, including by phosphorylation, which affects the 
stability of microtubule and the repertoire of interactions with microtubule-associated proteins [61]. 
Microtubule organization is typically illustrated as a radiating array of filaments that emanates from a 
single perinuclear centrosome that serves as the microtubule organizing center (MTOC) with dynamic 
plus ends projecting to the plasma membrane and minus ends anchored to gamma tubulin within the 
centrosome. However, this topology does not accurately document the microtubule arrays found in 
polarized cells. In many cell types microtubules are released from the MTOC and increasing evidence 
suggests that gamma-tubulin-dependent microtubule nucleation does not have to be connected with a 
conventional MTOC [62,63].  
In polarized epithelia, microtubules are organized in a non-centrosomal array aligned along the 
apical-basal polarity cell axis with minus ends apical and plus ends basal (Figure 2A) [64]. Anchoring 
of microtubule minus ends can occur at the most apical part of the cadherin-based adherens junction, 
called the zonula adherens [65]. Additionally, there is a meshwork of microtubules beneath the apical 
membrane  and  longitudinally  arranged  microtubule  bundles  around  the  nucleus  at  the  lateral 
membrane  (with  plus-ends  facing  the  basal  surface  of  the  cell)  [66].  This  unique  microtubule 
organization is established as epithelial cells polarize and provides for transcytosis and trans-epithelial 
intracellular traffic flow.  
The axons of neurons contain tracts of parallel microtubules with plus ends facing the distal axon 
and  minus  ends  oriented  toward  the  soma  [67].  In  a  pseudounipolar  sensory  neuron,  the  axon 
bifurcates near the soma, with the peripheral branch extending to the epidermis and the central branch 
to  the  spinal  cord.  Although  the  peripheral  branch  of  the  axon  functions  as  a  dendrite  from  an 
electrophysiological  perspective  (information  flows  toward  the  soma),  it  is  myelinated  and  
has a microtubule architecture that is axonal (plus ends are uniformly  oriented toward the axonal 
terminus)  (Figure  2A)  [68].  Axonal  microtubules  are  stabilized  by  a  number  of  neuron-specific  
microtubule-associated  proteins  including  tau-like  proteins  and  STOP  proteins  (stable  tubulin-only 
polypeptide) [67]. 
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2.1.3. Molecular Motors 
Facilitated intracellular transport is mediated along F-actin and microtubules by large molecular 
motor complexes that move cargoes by hydrolyzing ATP. The myosin family consists of actin-based 
motors  that  participate  in  muscle  contraction  and  actin-based  transport  (processive  myosins)  [69]. 
There  are  several  classes  of  myosins:  myosin  I  isoforms  are  membrane-associated  and  affect 
membrane dynamics, cytoskeletal structure, mechanical signal transduction and endosome processing; 
myosin II is the major contractile motor in muscles but also contributes to the dynamics of cortical 
actin and actin belts that connect adhering junctions [70]. Two major myosin II non-muscle isoforms 
play  different  roles:  myosin-IIB  participates  in  tension  maintenance  (actomyosin-generated  force 
combined with linkage to the cell surface receptors that is responsible for adhesion [71]) [72,73], 
whereas myosin-IIA isoform is more suited for F-actin sliding (anti-parallel sliding of actin filaments) 
due to its low affinity binding to actin [74]. Myosin IIA is proposed to cross-bind actin fibers with 
microtubules and restrain cell migration [75]. The absence of myosin IIA results in stabilization of 
microtubules, suggesting a role for myosin IIA in regulating a balance between the actomyosin and 
microtubule systems [75]. The last two major classes of myosins are myosin V and myosin VI, both 
noted for their processivity and contribution to vesicular transport [70].  
Figure  2.  Alphaherpesvirus  intracellular  transport,  dissemination,  and  neuroinvasion.  
(A) Alphaherpesviruses replicate in epithelia, which have complex multilayer architectures. 
The  epidermis  has  multiple  cell  types,  including  polarized  cells  (epithelial  cells;  EC) 
adjacent to the basement membrane (BM) which have microtubule bundles with minus 
ends oriented toward the apical surface. On top of the polarized layer may be multiple 
layers of epithelial cells. Merkel cells (MC) form punctae adherentia junctions (PAJ) with 
nerve  fibers  of  sensory  neurons  and  have  a  classic  microtubule  aster  emanating  from  
the  microtubule  organizing  center  in  the  perinuclear  region.  Viruses  enter  cells  by  
receptor-mediated fusion (1), followed by microtubule-based transport of the capsid and a 
small  number  of  capsid-associated  tegument  proteins  (2).  The  nucleus  is  the  final 
destination  of  the  virus  (3).  Newly  assembled  viral  particles  exit  the  nucleus  and  the 
resulting naked capsids (4) are delivered to the TGN for final assembly (5). Inside the 
TGN-derived  vesicles,  assembled  virions  are  transported  to  the  plasma  membrane  (6) 
where they exocytose (7). Virions can spread to the neighboring cells via cell-cell contact 
sites (8). Neuroinvasion may occur across the PAJ (9), following basal release of virions 
from EC in proximity to the nerve terminal, or by infection of exposed nervous endings. 
(B) Sensory neurons are a primary target of alphaherpesvirus virions. A part of the axon is 
magnified to show the architecture of the transporting virus particles, which depends on the 
directionality  of  transport.  Retrograde-transporting  particles  consist  of  the  capsid  and 
associated tegument proteins. Viral particles arising from reactivated infection primarily 
transport as fully-assembled virions inside vesicles (i); however virus components could be 
transported independently of each other (ii, iii; denoted with a question mark—see text). 
Viral particles at both stages of infection associate with kinesin and dynein motors. Viruses 2011, 3                         
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Figure 2.Cont. 
 
 
The  kinesin  superfamily  (KIF)  of  molecular  motors  consists  of  over  250  kinesin-like  proteins. 
Kinesins have a common fold and ancestry with myosins and G proteins [76]. The majority of kinesins 
work as a hetero-complex with non-motor proteins called kinesin light chains (KLCs). The kinesin 
superfamily is currently divided into 15 groups [77,78]. Kinesin-1 (conventional kinesin group), -2, -3, Viruses 2011, 3                         
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-4, -12, and -14 families consist of processive cytoplasmic kinesins that participate in vesicle and 
organelle  transport.  Kinesins  from  other  families  are  required  for  spindle  formation/maintenance, 
chromosomal  segregation,  kinetochore  capture  and  microtubule  dynamics.  The  kinesin-1  group 
contains  KIF5A,  KIF5B  and  KIF5C  isoforms,  where  KIF5A  and  KIF5C  are  neuron-specific  and 
KIF5B  is  ubiquitously  expressed  [79,80].  Transport  in  neurons  requires  a  differentiation  between 
axonal and dendritic transport as well as vesicle sorting, and several kinesins contribute to maintaining 
neuron polarity and function. KIF1A and KIF1B, kinesin-3 family members, are axon anterograde 
transporters  of  Rab3-containing  presynaptic  vesicles  [81,82].  Neuronal  kinesin-14  motors  (KIFC2  
and  KIFC3)  are  unusual  minus-end  directed  C-type  kinesins  that  are  proposed  to  play  a  role  in 
retrograde  transport  in  dendrites  and  axons  [83–85].  KIF17  (a  kinesin-2  family  member)  is  a  
dendrite-specific anterograde motor and is implicated in transporting N-methyl-D-aspartate receptor 
NR2B  subunit-containing  vesicles  associated  with  glutamatergic  neurotransmission  [86].  Another 
interesting neuron-specific kinesin is KIF3C, also a kinesin-2 family member, binds and transports 
Fragile X mental retardation 1 protein (FMRP), an RNA-binding protein, to local sites of protein 
synthesis in axons and dendrites [87]. KIF3C binds KIF3A, another kinesin-2 family member, and 
forms a heterogenic, neuron-specific, vesicle-associated motor protein complex [88]. Further diversity 
of the kinesin families is provided by numerous types and isoforms of associated KLC. For example, 
KIF5B can associate with various isoforms of KLC1 or KLC2 that arise from alternative splicing [89].  
Unlike kinesins, most mammals have only 3-5 genes encoding the predominant minus-end directed 
microtubule motor: Dynein. While the diversity of plus-end microtubule trafficking is conveyed by the 
large superfamily of kinesin motors, minus-end trafficking is coordinated by interactions of different 
regulatory  proteins  with  the  dynein  motor.  Heterogeneity  in  the  dynein  complex  dictates  motor 
stability, processivity, and cargo selectivity [90,91]. The dynein motor complex is the largest and most 
complex of the three classes of cytoskeletal motors: its structure consists of two heavy chains, three 
intermediate chains and four light chains. Heavy chains have a motor domain unlike those of kinesins 
and  myosins,  having  homology  with  the  AAA  superfamily  of  mechanoenzymes  [92].  Additionally, 
dynein typically functions in conjunction with the dynactin protein complex, which consists of at least 
ten additional proteins including: actin related protein 1 (Arp1), p150 (glued) and p50 (dynamitin) [93].  
Each  cytoskeletal  motor  has  a  specific  directionality.  Myosins  I  and  V  move  towards  the 
barbed/plus end of the actin filaments, while myosin VI moves in the opposite direction [94,95]. Most 
processive cytoplasmic kinesins move toward the plus end of the microtubule with the exception of 
members of the kinesin-14 group. The majority of minus-end directed motion along microtubules is 
achieved by the dynein/dynactin complex [96]. Thus, all traffic in non-polar mesenchymal cells from 
the  plasma  membrane  inward  toward  the  nucleus  is  dynein-dependent,  whereas  kinesins  transport 
cargoes toward the plasma membrane. Because polarized epithelial cells have microtubules spanning 
the cell with minus ends apical and plus ends basal, all transport toward the basolateral membrane is 
kinesin-based and transport in the apical direction is achieved via dynein [97,98]. In general, cargo 
transport switches from microtubules to F-actin near the cell periphery where myosins I, V and VI  
take over [99].  
Interestingly,  kinesin  and  dynein  can  work  independently  [100],  cooperatively  [100–102],  or 
competitively [103]. In addition, kinesin-1, dynein and myosin can form a heterocomplex that moves 
on  both  F-actin  and  microtubules  [104].  The  dynactin  complex  plays  a  key  role  in  bi-directional Viruses 2011, 3                         
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movement by promoting both dynein [105–107] and kinesin transport [107,108]. Moreover, p150
glued 
as well as another known dynein-binding protein (BICD2) can crosslink dynein and kinesin motor 
protein complexes and thus regulate bidirectional transport of vesicles and positioning of the nucleus 
[109,110]. In some circumstances, kinesin and dynein can interact with each other directly [111]. 
Cytoskeletal motor proteins are regulated by phosphorylation and by phosphorylation of associated 
proteins [112,113], and, in the case of myosins, are also regulated by calcium flux [98,114]. Myosins 
are also known to be regulated via ubiquitination of motors themselves [115], or myosin chaperone 
proteins [116]. Tubulin and actin are also substrates for ubiquitination [54,117]. Additionally, motor 
protein  regulation  occurs  at the level  of  cargo  binding  [112].  Within  this  complexity  of  transport 
regulation, it is important to note that microtubule- and actin-dependent transport are often coupled and 
coordinated [112,118]. While the big picture of cytoskeletal-based transport is far from complete, in 
general, the coordination of trafficking events and targeting of cargo delivery is modulated by coupling 
specific motors and cargo, adjusting motor activity, and transporting along cytoskeletal tracks that are 
themselves dynamic.  
2.2. Neuroinvasive Herpesviruses and the Cytoskeleton 
Herpesviruses interact with, and sometimes rearrange, the cellular cytoskeleton. These interactions 
occur throughout the infectious cycle: From extracellular viral particles attached to the surface of cells, 
viral structural components deposited into the cytosol upon initial entry, and de novo expressed viral 
proteins in the cell. Therefore, herpesvirus envelope proteins, tegument proteins, capsid proteins and 
non-structural proteins each have opportunities to enhance infection by subverting cytoskeletal function. 
2.2.1. Virus Entry: Initiation of Cytoskeleton Rearrangements 
Neuroinvasive herpesviruses initially attach to cells by binding heparin sulfate (HS)  on heparin 
sulfate proteoglycans (HSPGs). For HSV-1, binding to HS can be mediated by gC and, to a lesser 
extent,  by  gB  [119–121].  Virion  binding  to  cell  surface  HS  is  thought  to  promote  subsequent 
interactions with herpesvirus entry receptors by retaining virions at the plasma membrane. However, 
this conceptually passive virion retention mechanism also triggers a burst of signals into the virion and 
cell. HSV-1 virions undergo a structural deformation upon binding to cells that includes release of a 
tegument protein, pUL16, from the capsid. The effect this change has on subsequent viral entry is 
unclear; however, gC binding to HS is sufficient for its induction [122]. Meanwhile, HSPGs bound by 
gC,  as  shown  for  PRV,  relocalize  within  the  plasma  membrane  and  become  aligned  with  the 
underlying actin cytoskeleton [123]. In this regard, the virus appears to have co-opted a normal cellular 
function of HSPGs, which serve as a low-affinity receptors for many growth factors, align to the actin 
cytoskeleton  and  become  insoluble  to  Triton  X-100  upon  growth  factor  binding  [124].  This 
transmembrane  association  with  the  actin  cytoskeleton  is  thought  to  effectively  deliver  the  bound 
growth factor, or herpes virion as the case maybe, to its high-affinity receptor. 
Viral attachment to the cell surface can occur along finger-like protrusions referred to as filopodia. 
Attachment of HSV-1 to filopodia via gB-HS interaction connects virions to the retrograde actin flow, 
bringing them to the filopodia base at the cellular membrane [125]. This process, referred to as ―viral 
surfing‖ was originally documented for retroviruses, but is increasingly recognized as a common viral Viruses 2011, 3                         
 
 
951 
tactic to increase the efficiency of entry for both enveloped and non-enveloped viruses [126]. In cells 
plated at low density in culture filopodia increase the cell surface area, thereby increasing the number 
of virions that enter a cell independently of the multiplicity of infection (MOI). Formation of filopodia 
depends on activation of Cdc42, a Rho GTPase [127]. For HSV-1, binding of cell surface nectin by gD 
can deliver this signal, while inhibition of phosphoinositide 3 kinase (PI3K) antagonizes the gD signal 
and filopodia formation [128–130]. Therefore, viruses do not only surf but also induce the filopodia 
upon which surfing occurs. Inhibition of PI3K does not interfere with HSV-1 attachment or entry but 
does prevent incoming capsids from arriving at the nucleus [131]. Together, these findings suggest that 
HSV-1  surfing  may  direct  incoming  virions  to  productive  sites  of  viral  entry,  consistent  with  a 
suggestion that surfing helps to avoid the delivery of capsids into dense actin filament regions of the 
cortex  that  may  confine  the  capsid  and  hinder  subsequent  intracellular  transport  [126].  Although  
HSV-1 delivered to cells at exceedingly high MOI can induce filopodia formation [125], the initiation 
of this process may be more relevant in the context of cell-cell transmission of infection. Herpes 
glycoproteins  are  expressed  on  the  surface  of  infected  cells,  making  them  accessible  to  HS  on 
neighboring cells [132]. The triggering of Cdc42 in a target cell would likely establish a dynamic  
cell-cell junction that efficiently recruits emerging virions to the uninfected cell, functionally related to 
the virological synapse induced in T cells by HIV-1 [133] and notably by HSV-1 [134]. Perhaps 
related to the induction of filopodia, binding of gD to sensory neurons elicits a Cdc42 signal that 
results in the formation of axon varicosities, which are sites of herpesvirus entry and exit in neurons 
[135]. A related finding is seen in CNS neurons, which respond to gD binding by increasing synapse 
number on axons [45]. A general theme is therefore emerging that herpesvirus glycoproteins not only 
mediate  virion  entry,  but  also  remodel  both  neurons  and  non-neuronal  cells  by  triggering  actin 
dynamics through Cdc42 to make the cells more permissive to infection. 
Herpesvirus surfing and internal virion rearrangements represent exciting new areas of research, yet 
these  events  are  dispensable  for  infection;  pUL16,  gC,  and  the  HS-binding  activity  of  gB  are  all  
non-essential  for  HSV-1  propagation  in  culture  [136–141].  Furthermore,  the  role  of  the  actin 
cytoskeleton in herpesvirus entry is variable. HSV-1 entry into HEp-2 cells and PRV entry into PK15 
cells  are  sensitive  to  actin  depolymerization  with  cytochalasin  D  [123,142],  while  cytochalasin  D 
treatment of Vero cells does not impact HSV-1 or PRV entry [123,143]. Nevertheless, HS interactions 
are  essential  both  for  efficient  attachment  and  entry  [138].  These  facts  likely  speak  more  to  the 
limitations of studying viral infections in transformed tissue culture cell lines than they do about the 
relevance of the processes themselves. 
In  neurons,  HSV-1  enters  by  envelope  fusion  with  the  plasma  membrane,  typically  at  axon 
terminals [144–146]. The capsid must therefore navigate to a microtubule to engage in retrograde 
transport. Whether this is a passive or active process is not known. In some cell types, HSV-1 fusion 
occurs  after  endocytosis  [144,147,148].  Engagement  of  virion  gD  by  cellular  nectin  or  HVEM  is 
generally a prerequisite for fusion, but gD cannot be the only trigger for fusion as this protein is absent 
from  VZV  and  dispensable  for  PRV  cell-cell  transmission  [149–152].  While  far  less  is  known 
regarding  alternative  entry  receptors,  their  potential  roles  in  cytoskeletal  interactions  makes  them 
worthy of mention here. HSV-1 gB binds paired immunoglobulin-like type 2 receptor alpha (PILR) 
[153,154], and non-muscle myosin IIA heavy chain IIA (NMHC-IIA) [155]. PILR is one of two 
paired  antagonistic  receptors  (PILRis  inhibitory  andPILR  is  stimulatory)  mainly  expressed  on Viruses 2011, 3                         
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myeloid cells such as monocytes, macrophages, and dendritic cells, and plays an important role in 
regulation of immune cells [156,157]. The role of PILR in HSV infection in vivo is not known, 
however, it is possible that PILR, along with HMEV and nectin-1, plays a role in HSV-2 entry into 
retinal pigment epithelial [158]. Contractile myosin IIA, a major participant in control of cell adhesion, 
migration,  and  tissue  architecture,  is  an  unusual  receptor  for  HSV  entry,  primarily  because  of  its 
cytosolic  localization.  However,  NMHC-IIA  was  redistributed  and  accumulated  at  the  plasma 
membrane 2–15 min after HSV-1 infection. Moreover, NMHC-IIA was reported to become cell-surface 
exposed,  allowing  for  its  interaction  with  HSV  gB  to  promote  virus-cell  fusion.  Knockdown  of 
NMHC-IIA  or  blocking  NMHC-IIA  with  antibody  inhibited  HSV  infection  [155].  Furthermore, 
NMHC-IIA  subcellular  redistribution  depends  on  phosphorylation  by  Ca
2+-calmodulin-dependent 
myosin light chain kinase and specific inhibitor of this kinase (ML-7) or chelation of Ca
2+ decreased 
Vero cell susceptibility to HSV-1 [155]. It is noteworthy that virus surfing is dependent on myosin II, 
and inhibition of myosin II with blebbistatin significantly reduces viral infection [126,159]. 
VZV  gB,  gH/gL  and  HSV-1  gB  were  recently  shown  to  interact  with  myelin-associated 
glycoprotein (MAG) [160]. MAG is a component of myelin in the CNS and PNS and promotes neurite 
outgrowth during embryonic development. MAG can form a complex with 1-integrin and promote 
axonal growth by modulating cytoskeletal dynamics, cell adhesion, and migration [161]. 
Following entry, Cdc42 signaling appears to provide a second enhancement of viral infectivity. 
Phosphorylation of Cdc42 leads to activation of the related GTPase, RhoA, and activation of this 
temporal Cdc42/RhoA cascade is observed during HSV-1 infection [127]. RhoA can effect changes in 
the actin cytoskeleton through Rho-associated coiled-coil containing protein kinase 1 (ROCK1), which 
in turn signals to focal adhesion kinase (FAK) [162,163]. Both ROCK1 and FAK are implicated in 
HSV-1 and EHV-1 infectivity downstream of entry [164,165]. These observations are consistent with 
the finding noted earlier that PI3K inhibition also blocks infection at a post-entry step [131]. For  
EHV-1, this  may  result in  productive caveolin-dependent endocytosis and  subsequent intracellular 
transport  that  is  dependent  on  depolymerization  of  F-actin  and  intact  microtubules  [166,167]. 
Activation of Cdc42 leads to stabilization of the microtubules [168] that, by providing a route for 
capsid transport to the nucleus, may provide one mechanism for enhanced permissivity of herpesvirus 
infection following entry. 
2.2.2. Transport of Viral Particles in the Cytoplasm 
Upon entry, membrane fusion deposits the capsid in the cytosol and leaves glycoproteins and the 
envelope behind as a contiguous part of the cellular membrane [144–146,169–174]. Tegument proteins 
have a mixed fate during this disassembly step. Tegument proteins pUL36 (VP1/2), pUL37 and pUS3, 
remain capsid bound and are constituents of the capsid-transport complex that ultimately docks at 
nuclear pores, while other tegument proteins disassociate from the capsid [175–178]. Long distance 
transport of capsids (i.e., from the site of entry to the nucleus) occurs along microtubules (Figure 2A 
and  2B)  [143,179].  In  most  cells  minus-end  directed  transport  along  microtubules  moves  capsids 
toward the nucleus, and is termed retrograde. Conversely, anterograde transport is directed towards 
microtubule  plus  ends  and  moves  capsids  toward  the  plasma  membrane.  In  neurons,  retrograde 
transport  is  responsible  for  moving  capsids  from  axon  terminals  to  the  neuronal  cell  body,  while Viruses 2011, 3                         
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reactivated herpesvirus infection undergo anterograde transport from the cell body to axon terminals. 
A  notable  exception  to  this  rule  is  observed  in  polarized  epithelia,  which  have  longitudinal 
microtubules extending lengthwise within the cell and oriented with minus-ends apical and plus-ends 
basal (Figure 2A) [66,180–182]. Both apical and basolateral entry of HSV-1 into polarized epithelial 
cells (MDCK) was reduced when cells were treated with nocodazole (a microtubule-depolymerizing 
drug),  implicating  microtubules  in  capsid  transport  from  both  directions  [183].  Transport  of 
alphaherpesviruses  along  microtubules  is  dependent  upon  cellular  microtubule  motor  complexes, 
which  are  too  large  to  be  encoded  by  a  herpesvirus,  to  achieve  these  transport  events.  Although 
selective  depolymerization  of  microtubules  with  nocodazole  demonstrates  that  the  microtubule 
cytoskeleton  is  not  essential  for  herpesvirus  infection  in  transformed  cell  lines  [143,183],  passive 
diffusion is not sufficient to deliver herpesvirus capsids from an axon terminals to neuronal cell bodies 
[68,179].  Therefore,  microtubule-based  axon  transport  is  a  critical  factor  in  alphaherpesvirus 
neuroinvasion, the establishment of latency, and reactivated infection. 
2.2.2.1. Retrograde Transport: Ingress 
The first obstacle that viral particles encounter on the way to the nucleus is a thick layer of cortical 
actin.  As  discussed,  interactions  of  virus  with  the  cell  surface  receptors  are  expected  to  initiate  
Cdc42-dependent rearrangement of the actin cytoskeleton. It is not known, however, if rearrangement 
of actin is required for early stages on alphaherpesvirus infection in vivo. In Vero cells and cultured 
sensory neurons, actin-depolymerization drugs have no impact on virus entry [143,184]. Conversely, 
the microtubule cytoskeleton and long-range microtubule-dependent transport are very important for 
alphaherpesvirus infection, especially in regard to axonal transport. Incoming capsids are often seen 
accumulating at the MTOC prior to reaching the nuclear membrane, where they dock at nuclear pores 
and release genomic DNA into the nucleus [143]. Minus-end directed transport towards the MTOC 
requires the dynein motor complex, and dynein association with the vertices of incoming capsids has 
been detected by immunoelectron microscopy [143]. Disruption of the dynactin complex, a cofactor of 
microtubule motors including dynein [91,108], interferes with retrograde transport of incoming capsids 
[143,185]. High-speed time-lapse microscopy has allowed for tracking of individual fluorescently-
labeled  capsids  in  cultured  sensory  neurons,  revealing  that  transport  occurs  by  fast  axonal  flow  
(>1  µm/s),  is  saltatory,  and  bi-directional  [177,186].  Bi-directionality  indicates  that  capsids  are 
simultaneously bound to microtubule motors of opposite polarity (i.e., dynein and a kinesin), and the 
capacity for capsids to bind opposing motors was recently demonstrated (Figure 2B) [187]. The reason 
for  recruitment  of  a  plus-end  directed  kinesin  on  the  incoming  capsid  is  not  immediately  clear; 
however, the final transport of capsids from the MTOC to the nucleus may be achieved by a regulatory 
switch from dominant dynein activity to motion favoring kinesin. In fact, little is known regarding how 
herpesvirus  capsids  transit  from  the  MTOC  to  nucleus,  and  whether  this  is  a  facilitated  process. 
Because the MTOC resides in close proximity to the nucleus in many cells types, passive diffusion 
may be sufficient for this final step. Adenoviruses, which like herpesviruses transport to the MTOC 
and then dock at nuclear pores, actively sense nuclear proximity based on the nuclear export activity of 
the CRM1 (Chromosome Region Maintenance 1) protein [188]. Either a protein exported from the 
nucleus by CRM1, or CRM1 itself, is necessary for the MTOC to nuclear pore transition; whether a Viruses 2011, 3                         
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similar event occurs during herpesvirus infection has not been documented. A second possible role for 
kinesin recruitment on incoming capsids is in polarized epithelia. Because these cells have longitudinal 
microtubules oriented with minus ends apical, an incoming herpesvirus capsid may require kinesins to 
move toward the nucleus. 
A number of HSV proteins interact with microtubule motors, including: pUL34, pUL35 (VP26), 
pUL46 (VP11/12), pUL56 and pUS11 [189–192]. Only one of these is known to remain associated 
with incoming viral capsids: the exterior capsid component VP26 [177,193,194]. When microinjected 
into Hep2 cells, capsids assembled in insect cells using recombinant baculovirus vectors display an 
enhanced predilection to redistribute near the nucleus when VP26 is present  [190]. Opposing this 
finding,  capsids  isolated  from  infected  cell  nuclei  fail  to  bind  dynein  and  move  on  microtubules  
in vitro suggesting that capsid protein components, including VP26, do not contribute to retrograde 
transport  [195].  These  apparently  contradictory  findings  are  difficult  to  resolve  by  nature  of  the 
different assays used by the studies. However, because recombinant HSV-1 and PRV lacking VP26 
move  retrograde  effectively  in  cell  lines  and  in  primary  sensory  neurons  in  culture  and  in  vivo  
[196–198],  the  VP26-dynein  link  is  at  best  a  redundant  mechanism  and  additional  recruitment 
mechanisms  must  exist.  Tegument  proteins  are  likely  candidates  for  tethers  between  capsids  and 
dynein.  Many  of  these  proteins  have  been  shown  to  be  dispensable  for  dynein  recruitment  either 
genetically  or  biochemically,  including:  pUL4,  pUL11,  pUL13,  pUL14,  pUL21,  pUL41  (VHS), 
pUL46 (VP11/12), pUL47 (VP13/14), pUL48 (VP16), pUL49 (VP22), pUL51, pUS3, pUS11, ICP4 
and ICP34.5 [187,197]. 
By process of elimination, the best candidate viral proteins for dynein recruitment are two tegument 
proteins: pUL36 (VP1/2) and pUL37. The VP1/2 tegument protein is the largest protein encoded in the 
herpesvirus  genome  (>3000  a.a.),  and  has  increasingly  been  a  focus  of  investigation.  The  protein 
performs  essential  functions  during  initial  and  late  infection.  Incoming  capsids  require  VP1/2  to 
release  DNA  into  the  nucleus  upon  docking  at  nuclear  pore  complexes  [199,200],  and  outgoing 
progeny  capsids  require  VP1/2  for  assembly  and  final  envelopment  of  infectious  particles  in  the 
cytoplasm [201–203]. Because of the central role VP1/2 serves in virion assembly and its large size, 
the protein is likely a scaffold for the recruitment of other tegument, and, possibly, envelope proteins. 
To date, only two other viral proteins have been confirmed as VP1/2 binding proteins: The pUL25 
capsid  protein  [204–206]  and  the  pUL37  tegument  protein  [207,208].  Several  additional  VP1/2 
binding proteins have been identified in yeast-two-hybrid screens, including: pUL17, pUL18 (VP23), 
pUL26 (VP24), pUL31 and VP16 [204,209]. In addition, a 150 kD protein that is likely VP5 (major 
capsid protein) co-immunoprecipitates with VP1/2 from infected cells [210]. VP1/2 is associated with 
capsids vertices via the pUL25 interaction that is possibly strengthened through additional interactions 
with the pUL17, VP5 and VP23 capsid proteins [204,205,211–213]. The interaction of VP1/2 with the 
capsid surface, and pUL37 with VP1/2, constitutes these two tegument proteins as components of the 
―inner‖  tegument.  Deletion  of  VP1/2  or  pUL37  in  HSV-1  or  PRV  results  in  accumulation  of 
unenveloped  capsids  in  the  cytosol,  implying  that  both  proteins  are  required  for  virion  assembly  
[201–203,214,215].  Because  VP1/2  is  an  essential  herpesvirus  protein,  null  mutants  unfortunately 
cannot be  examined for transport defects during initial infection. However, VP1/2 is essential for 
cytoplasmic transport of progeny capsids post replication, strengthening its candidacy as a microtubule 
motor  recruitment  protein  [216].  The  pUL37  tegument  protein  is  essential  in  HSV-1  [217],  but  Viruses 2011, 3                         
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pUL37-null PRV maintain some residual propagation [215]. This has allowed for a direct study of the 
role of pUL37 in nuclear delivery of incoming PRV capsids, and a substantial defect was identified 
[218]. It may be of interest that pUL37 is not required for delivery of HSV-1 capsids to nuclei when 
infected cells are artificially fused with uninfected cells to form syncytia [219]. Assuming that delivery 
of  capsids  emerging  from  the  infected  nucleus  to  uninfected  nuclei  within  the  syncytium  uses 
microtubule transport, then the pUL37 defect seen in PRV may be due to a deficiency in another early 
step of infection, such as overcoming the cortical actin barrier. Isolation of capsids from extracellular 
HSV-1 particles followed by salt extraction demonstrates that capsid/tegument complexes have the 
capacity to bind kinesin-1, kinesin-2, dynein and dynactin independently and via different sites, and 
that  these  interactions  likely  occur  with  proteins  of  the  inner  tegument  [187].  However,  motor 
recruitment by capsid proteins cannot be ruled out yet: Although capsids isolated from infected cell 
nuclei fail to bind microtubule motors, the capsid proteins could be post-translational modified in the 
cytosol. How dynein is recruited to cellular cargoes is not fully understood, and because functionally 
significant interactions with dynein have been difficult to pin down for any virus, it seems likely that 
this recruitment may not be by a single viral protein-dynein interaction. 
2.2.2.2. Assembly, Egress and Cell-to-Cell Spread 
Herpesvirus capsids assemble in the nucleus. HSV-1 and PRV induce the formation of intranuclear 
actin filaments, and these may promote capsid access to the inner nuclear membrane. Intranuclear 
HSV-1  capsids  display  actin-dependent  directional  movement  [220].  Moreover,  rod-like  structures 
thought to be made of actin are observed bridging capsids and primary envelopes, further suggesting a 
possible  role  for  actin  in  inner  nuclear  membrane  budding  [221].  Although  there  is  some  
debate  regarding  the  pathway  of  capsid  egress  from  the  nucleus,  the  favored  model  states  that 
membrane-bound capsids that reside in the lumen of the nuclear membrane fuse with the outer nuclear 
membrane and release naked capsids into the cytosol (de-envelopment) [222–224]. Naked capsids 
proceed  to  the  site  of  secondary  envelopment  where  final  assembly  takes  place.  The  process  of 
envelopment/de-envelopment/secondary  envelopment  is  conserved  between  different  groups  of 
alphaherpesviruses  [225]. Tegument acquisition around capsids occurs in  at least two steps:  inner 
tegument proteins bind to capsids in the cytosol, and outer tegument proteins associate with nascent 
trans-Golgi  network  (TGN)-derived  membranes  rich  in  viral  glycoproteins  and  are  acquired 
concomitantly during final membrane acquisition [226]. As will be discussed, there is evidence that 
cytosolic capsids participate in microtubule-based transport both prior and subsequent to secondary 
envelopment, and that these two transport steps likely occur by different mechanisms. The architecture 
of epithelial and neuronal polarity also places restrictions on how nascent virus particles must be 
targeted for infections to be productive. It is not known how viruses recruit motors, nor how the 
different stages of transport are targeted.  
2.2.2.2.1. Delivery to TGN and Secondary Envelopment 
Up to  the  point of capsid egress from the nucleus  to the cytosol, the infection  has  progressed 
through  immediate-early  and  early  viral  gene  expression,  DNA  replication,  late  gene  expression, 
capsid assembly, and genome encapsidation. The cytosol has also undergone dramatic alterations since Viruses 2011, 3                         
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the incoming capsid traveled retrograde to the MTOC and nuclear pore hours before. It is in this 
modified environment that progeny capsids de-enveloping from the nucleus now reside. All structural 
proteins, including tegument and envelope constituents are present and ready for assembly. 
The  cytoplasmic  assembly  pathway  has  been  dissected  genetically  and  observed  by  electron 
microscopy. PRV deleted for pUL36 (VP1/2) lacks all evidence of tegument protein assembly on 
capsids, supporting the idea that VP1/2 is a scaffold for the assembly of additional tegument proteins 
[202]. PRV deleted for pUL37 remains competent to assemble VP1/2 onto capsids [208,215]. PRV 
deleted for pUL48 (VP16) or pUL3.5 remains competent to assemble both VP1/2 and pUL37 onto 
capsids [227]. In each of these three scenarios, naked capsids accumulate in the cytosol of the infected 
cell and generally fail to proceed to final envelopment. However, differences between these defective 
phenotypes have been noted. Cytosolic UL36-null capsids are dispersed, while cytosolic UL37-null 
capsids tend to stick together and form clusters. In contrast, the UL3.5-null capsids are less prone to 
aggregate and tend to localize near the Golgi network. These observations are consistent with a role of 
VP1/2  in  capsid  trafficking  in  the  cytosol,  with  pUL37  either  preventing  capsid  aggregation  or 
performing an auxiliary role in the transport process. Live-cell fluorescence imaging of PRV capsids in 
infected cells reveals the highly dynamic nature of these viral particles  [216]. Capsid transport is 
primarily dependent on microtubules although actin makes a small, but measurable, contribution [216]. 
Consistent with a role for VP1/2 in virus trafficking, fluorescent capsids expressed by PRV deleted for 
pUL36 (VP1/2) fail to transport along microtubules. Interestingly, the UL37-null exhibits decreased 
transport, but transport is not abrogated [216]. Because UL37-null PRV has a secondary-envelopment 
defect, this result indicates that naked capsids participate in microtubule transport during the egress 
phase of infection. The composition of the de-enveloped capsids may be similar, perhaps identical, to 
incoming capsids following entry: Both capsids are deposited in the cytosol and are bound to VP1/2, 
pUL37 and pUS3. As discussed, entering capsids are primed to recruit dynein, traffic to the MTOC, 
and continue to nuclear pores. Although speculative, it is possible that de-enveloped capsids emerging 
from the nucleus follow the same paradigm, but upon trafficking toward the MTOC become diverted 
by  the  viral  tegument  and  glycoproteins  accumulated  in  the  Golgi/TGN.  There  are  interactions 
between  capsid-inner  tegument  complexes  and  membrane  patches  containing  glycoproteins  and 
tegument  proteins.  For  example,  an  interaction  between  pUL21  (tegument,  binds  to  capsids),  
pUL16 (tegument), and pUL11 (transmembrane) could trigger budding into the secretory pathway 
[207,228–231]. In this way, the de-enveloped capsids are removed from the cytosol and follow the 
trafficking  pattern  of  the  biosynthetic  pathway  to  ultimately  be  exocytosed  from  the  cell  as  an 
infectious  virion.  There  is  a  recent  suggestion  that  the  VP26  capsid  protein  may  assist  in  
re-envelopment  by  binding  the  tetraspanin  family  member,  CTMP-7  [232].  Several  viruses  (HIV, 
HCV, HTLV-1, etc.) use the tetraspanin family of proteins to bud out of infected cells [233]. 
In addition to binding cytosolic, VP1/2 and pUL37 can associate  with outer tegument proteins 
independently of capsids. Localization of pUL37 to the TGN is dependent on VP1/2, which likely 
serves as a tether to the tegument proteins localized in the TGN membrane [234]. In fact, the VP16 
tegument protein interacts with VP1/2 based on yeast-two-hybrid screen data, and VP16 is required for 
the incorporation of both VP1/2 and pUL37 into PRV light particles (viral particles released from cells 
that contain tegument and envelope but lack a capsid) [207,227]. 
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2.2.2.2.2. TGN to Plasma Membrane Transport in Epithelia  
Delivery of enveloped virions newly budded into the TGN to the plasma membrane is the final step 
of virus egress leading to the exocytic event. The polar architecture of epithelial cells allows for apical, 
basal  and  lateral  virion  release.  In  general,  apical  release  is  expected  to  provide  for  transmission 
between hosts, while lateral release would promote viral dissemination within the epithelial sheet and 
basal  release  would  deliver  virions  to  nerve  endings  (Figure  2A).  The  unique  orientation  of 
microtubules  in  polarized  epithelia  predicts  that  kinesins  would  promote  basal  release  and  dynein 
apical release [66,180]. However, in HSV-1 infected epithelia in culture the majority of virions release 
laterally [235]. The polar release of virions does not appear to be a default pathway, but rather viral 
proteins likely remodel the secretory pathway as the infection progresses with the TGN dramatically 
redistributing to the lateral cell periphery [236]. TGN fragmentation and redistribution is dependent 
upon microtubules and is thought to enhance viral assembly [237–239]. How viruses become directed 
to release basally to allow for neuroinvasion is even less clear, but the lack of neural input in most 
tissue culture epithelia models could indicate that a neuron-epithelial junction is required for effective 
basal targeting in epithelial cells. When epithelial cells are co-cultured with neurons, HSV-1 readily 
transmits from epithelia to neurons [240]. 
HSV-1 virions in the TGN require protein kinase D (PKD) to release from cells [241]. PKD is a 
member of the diacylglycerol (DAG)-binding Ser/The kinases that are involved in fission of vesicles 
from the TGN [242]. Notably, PKD also directs basolateral targeting of small cargoes and therefore is 
likely important for epithelial-neuron transmission (i.e., neuroinvasion) [243]. In a rat model, PRV 
neuroinvasion requires a deubiquitinase (DUB) activity embedded in the amino-terminus of the pUL36 
(VP1/2) inner tegument protein while lateral dissemination remains intact with a DUB mutant virus 
[244]. Because DUB mutants infect neurons and spread within the rat nervous system equivalently to 
wild-type PRV following intracranial infection, the DUB mutant phenotype may be explained by a 
lack  of  basal  release  from  epithelia,  which  would  be  in  keeping  with  the  observation  that  VP1/2 
recruits kinesin to TGN-derived vesicles containing enveloped HSV-1 and promotes their transport 
along microtubules in vitro [245,246]. Although, VP1/2 is traditionally viewed as an inner-tegument 
protein and binds directly to the capsid surface via an interaction with pUL25 [205,206], there are 
several lines of evidence supporting that a subpopulation of capsid-free VP1/2 protein interacts with 
membranes during infection. First, VP1/2 is a component of L-particles [227,247]. Second, a fraction 
of VP1/2 is released from virions following extraction with non-ionic detergent [195]. Third, VP1/2 
and pUL37 colocalize to the Golgi independently from capsids [234]. Therefore, VP1/2 may act apart 
from capsids to recruit kinesin to the outer (cytosolic) surface of cellular vesicles containing virions. 
Alternatively, capsid-bound VP1/2 may recruit kinesin to partially budded viral particles that are not 
fully closed [246]. The potential for interactions between VP1/2, PKD and kinesin are currently fodder 
for  speculation,  but  these  multiple  findings  provide  initial  glimpses  into  what  is  undoubtedly  a 
complex viral rewiring of the secretory pathway. In keeping with this scheme, we have determined that 
VP1/2  binds  to  conventional  kinesin  (kinesin  I)  and  directs  TGN-derived  vesicles  to  the  cellular 
periphery  [248].  In  cultured  hippocampal  neurons,  knockdown  of  PKD  redirects  transport  of 
endogenous  cargoes  to  axons  whereas  expression  of  a  dominant  negative  PKD  results  in  mixed Viruses 2011, 3                         
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transport to both dendrites and axons [249]. Herpesviruses could direct polar release by modulating 
PKD activity. 
Microtubule transport in epithelia cells leading to polar release of virions may involve additional 
viral proteins that can bind kinesin motors. HSV-1 pUS11 binds KIF5B and KLC-like protein PAT1 
[192,250]. However, pUS11 is a non-essential tegument protein that binds dsRNA and shuttles in and 
out of the nucleus, and is not conserved among members of Alphaherpesvirinae. HSV-2 membrane-
associated pUL56 interacts with KIF1A (a kinesin-3 family member) and localizes to the Golgi and 
associated vesicles [189,251]. Although pUL56 is conserved in the neuroinvasive herpesviruses [13] it 
is also dispensable for virus propagation [252]. Ultimately, the microtubule transport of TGN-derived 
vesicles harboring virions to the plasma membrane is not sufficient for exocytosis: Myosin motors 
mediate the last step of alphaherpesvirus delivery to the plasma membrane by navigating the cortical 
actin cytoskeleton [253,254]. 
2.2.2.2.3. Anterograde Axon Transport  
After reactivation from latency, viral particles are sorted to axons from neural soma and transport to 
axon terminals where infectious particles disseminate. This anterograde-directed movement is crucial 
for successful re-infection of innervated tissue after reactivation from latency and successful spread 
between hosts. Whether virus components are simply passive cargoes that select the correct transport 
vesicle or actively promote transport to distal axons is not clear. In support of the latter, herpesviruses 
encode  membrane  proteins  which  contain  sorting  signals.  In  general,  sorting  signals  can  have  
two  overlapping  functions:  targeting  proteins  to  secretory  vesicles  and  directing  secretory  vesicle 
traffic [255]. Sorting motifs have been studied in several herpesvirus membrane-anchored proteins. For 
example, anterograde transport of PRV virions in axons, as well as transport of gB, gC, gD and gE, is 
dependent on a classic Y-based sorting motif (YXXϕ, where Y is tyrosine, ϕ is a large hydrophobic 
amino  acid)  in  pUS9  [256,257].  Complementation  of  PRV  pUS9  with  EHV-1  and  BHV-1  pUS9 
suggested similar function of pUS9 in these viruses. Conversely, failure to complement PRV pUS9 
with pUS9 from HSV-1 and VZV suggested that although pUS9 is highly conserved in alphaherpesviruses, 
functional differences exist between some homologs [258]. The role of lipid rafts in transport of viral 
particles is becoming more evident, not only for virus entry, but also for anterograde transport. HSV-2 
pUL11 and pUL56, HSV-1 vhs and pUL11, and PRV pUS9, gB, gE and gD all associate with lipid 
rafts [259]. While the functional significance of these associations is not clear, PRV pUS9 association 
with lipid rafts is essential for pUS9-dependent axonal sorting [260]. 
Although  virally-encoded  membrane  proteins  participate  in  axon  targeting  of  viral  particles, 
whether this sorting occurs prior or subsequent to final capsid envelopment in the cytoplasm has been 
debated. Initial investigations of HSV-1 in axons by electron microscopy yielded results from several 
laboratories  documenting  fully-assembled  virions  within  vesicles.  Inoculation  of  HSV-1  into  the 
footpads  of  mice  allowed  for  the  examination  of  DRG  axons  in  vivo.  Axons  emanating  from  
heavily-infected neural somas within DRG contained virions in vesicles [261]. Although this analysis 
was of proximal axons located within ganglia, two subsequent studies found virions in vesicles within 
myelinated regions of the spinal cord in a similar infection model [262], and in retinal ganglion cell 
axons following inoculation of HSV-2 into the vitreous chamber of the eyes of rabbits [263]. Together, Viruses 2011, 3                         
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these studies yielded similar results for HSV-1 and HSV-2 in different neuron types at either the 
proximal  or  mid  axon  using  two  different  animal  models.  Similar  findings  with  HSV  were 
subsequently reciprocated in axons of the mouse trigeminal ganglion [264] and in rat sensory neurons 
in a two-chamber culture model [172]. These findings were challenged in 1994 by a study of HSV-1 in 
a two-chamber culture model using human neurons, which concluded that the anterograde transport of 
HSV-1 in axons occurred prior to final envelopment of the capsid: 100% of capsids in axons, both in 
proximal and distal regions, transported anterograde without envelopes [265]. The implication was that 
HSV envelope components must transport independently of the capsid to the distal axon where final 
envelopment would occur just prior to exocytosis (Figure 2B). Support for this model was gained by 
immunogold-EM [266]. Very recently, two additional laboratories examined this issue by conducting 
electron  microscopic  observations  of  HSV-1  infections  in  axons  of  cultured  neurons:  Both  found 
predominantly  enveloped  virus  particles  resident  in  vesicles  [267,268].  Similar  studies  have  been 
conducted with PRV and have provided consistent support for envelopment preceding anterograde 
axon transport [269,270]. 
One reason that so much effort has been devoted to the issue of herpesvirus compositional state 
during axon transport is its relevance to understanding the mechanism of the transport process. If 
unenveloped capsids can transport anterograde in axons without membrane components, then capsids 
must recruit and activate kinesin motors to mediate this process. While there is good evidence that 
capsids/tegument complexes bind kinesin motors, it is not clear if these associations function to deliver 
capsids to distal axons during infection [187]. Two recent studies have attempted to address this issue 
by performing time-lapse imaging of recombinant HSV-1 strains encoding two fluorescent tags: one 
fused to the capsid surface and one to an envelope glycoprotein. Both studies confirmed that capsids 
co-transport  anterograde  with  membrane  components,  consistent  with  the  majority  of  electron 
microscopic studies reported for HSV-1. However, different conclusions were reached regarding the 
capacity for capsids to transport anterograde in axons prior to envelopment. In one case, a minority of 
capsids undergoing anterograde trafficking lacked detectable glycoprotein signal [177], while in the 
other glycoprotein signal could not be detected for the majority of these particles [271]. Detecting 
glycoprotein  association  with  individual  diffraction  limited  capsids  is  not  trivial,  and  lack  of 
glycoprotein detection could easily arise from limitations in the sensitivity of fluorescence emission 
detection during the short exposures (<1 s/frame) imposed by time-lapse imaging. Careful attention 
needs to be given to the imaging method, light source emission intensity, and detector sensitivity used 
in such studies. Additionally, because these studies used different recombinants of HSV-1, a side-by-side 
comparative  examination  of  both  recombinants  should  further  help  resolve  this  important  issue. 
However, these approaches cannot easily rule out that a minority of capsids traffic anterograde in 
axons independently of the secretory pathway. While it is premature to conclude that capsids engage in 
long-distance axon transport by directly recruiting kinesin motors, the intriguing possibility remains. 
Live  imaging  of  fluorescently-tagged  egressing  PRV  and  HSV-1  viruses  showed  that  both  are  
co-transported with vesicle-associated membrane protein 2 (VAMP2), which is a part of the docking 
and/or fusion machinery of synaptic vesicles with the presynaptic membrane and a marker of axonal 
transport [272]. EM studies show that transport of HSV-1 viral glycoproteins and tegument proteins 
happens inside TGN-derived tubularvesicular membrane structures or large dense-core vesicles, and 
co-localizes with key anterograde traffic proteins: Rab3A, SNAP-25, GAP-43 and kinesin-1 [273]. Viruses 2011, 3                         
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These studies are beginning to unravel the aspects of the secretory pathway these viruses hijack for 
dissemination out of the nervous system.  
High-speed time-lapse microscopy  of  fluorescently-labeled PRV  capsids  in  dissociated  cultured 
sensory  neurons  revealed  that  transport  during  egress  occurs  by  fast  axonal  flow  (~2  µm/s),  is 
saltatory, and bi-directional [274]. Remarkably, VZV reactivating in a 9-year-old boy was recently 
estimated to travel at 1.3 µm/s in the sciatic nerve [275]. The similar velocities reported in these two 
studies  are  perhaps  even  more  remarkable  in  that  the  velocity  reported  for  PRV  was  an  average 
velocity of runs of continuous motion. These runs were punctuated by periods during which capsids 
were briefly stalled, attesting to the saltatory nature of the motion, that were not factored into the 
reported velocities. Therefore, the PRV and VZV velocities may be even a closer match despite one 
being measured in a tissue culture model and the other in a human leg. 
2.2.3. Viral Protein-Induced Cytoskeleton Rearrangements  
There are a number of alphaherpesvirus proteins known to induce changes in the host cytoskeleton 
directly  or  through  modulation  of  regulatory  molecules.  For  example,  HSV-2  anti-apoptotic  gene 
ICP10PK  influences  survival  of  infected  and  adjacent  neurons  via  the  Ras  signaling  pathways 
MEK/ERK and PI3-K/Akt. Activation of these pathways causes neurons to release vascular endothelial 
growth  factor  (VEGF)  and  fractalkine  [276],  and  stabilize  microtubules  via  phosphorylation  of 
microtubule-associated protein 1B (MAP1B) [277,278].  
The actin cytoskeleton is affected by pUS3 kinase in PRV, BHV-1, and HSV [279–284]. pUS3, 
along  with  another  viral  kinase,  pUL13,  is  also  important  for  efficient  TGN  budding  and  proper 
anterograde transport [178]. pUS3 induces rearrangements in the actin cytoskeleton via activation of 
the PAK family of kinases, which leads to disassembly of actin stress fibers and induction of cellular 
protrusions, both of which are proposed to enhance cell-cell spread and viral egress [285]. Although 
attenuated in the natural host (pigs) [286,287], PRV US3-null viruses have only slight attenuation  
in  vitro  and  in  a  mouse  intranasal  infection  model,  with  delayed  neuroinvasive  symptoms  [288].  
HSV-2  pUS3  downregulates  JNK/c-Jun  phosphorylation  in  vivo  [289],  preventing  virus-induced 
neuronal apoptosis in peripheral neurons and promoting spread of HSV-2 into the CNS [290]. HSV-2 
US3-null viruses are attenuated in mice following either footpad or intraperitoneal inoculation, but 
only moderately attenuated following corneal and intracerebral inoculation [291,292]. Based on these 
findings,  pUS3  was  proposed  to  determine  the  neuroinvasive  phenotype  of  HSV.  In  addition  to 
induction  of  apoptosis,  the  JNK/c-Jun  cascade  regulates  microtubule  stability  in  axons  by 
phosphorylating MAP1B, MAP2, tau, and other microtubule-associated proteins, which participate in 
regulation of microtubule stability in axons [293]. The interphase microtubule network is regulated by 
kinesin-1/JNK, which inhibits microtubule depolymerization, a novel function for conventional kinesin 
[294]. The effect of pUS3 on the actin cytoskeleton and possible regulation of the microtubule network 
via the JNK/c-Jun cascade are pro-survival, in line with the anti-apoptotic properties of pUS3 in a 
mouse intranasal model [295].  
pUS3 also phosphorylates VP22, which is one of the most abundant tegument proteins [296–298]. 
Overexpression of HSV-1 VP22 induces stabilization and hyperacetylation of microtubules [299,300], 
which  promotes  motor  binding  and  increases  microtubule-associated  trafficking  [301,302].  VP22 Viruses 2011, 3                         
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interacts with mapmodulin (Golgi trafficking), template activating factors Ia and Ib (cyclin-dependent 
nucleosome and microtubule regulation), NMHC-IIA (non-muscular contractile myosin, HSV-1 entry 
receptor)  [253],  and  microtubules  [299].  In  VZV,  ORF9  (VP22  homologue)  causes  ORF66  (US3 
homologue)-dependent  redistribution  of  IE62  from  the  nucleus  into  the  cytoplasm,  where  they  
co-localize with microtubules. Bovine herpesvirus VP22 (BVP22) has similar affinity for microtubules 
in the cytoplasm, but this association is less pronounced compared with HSV-1 and VZV VP22 [303]. 
Interestingly, HSV-1 VP22 and BVP22 are capable of inducing intercellular trafficking of nucleic 
acids  and  proteins  between  the  cell  of  origin  and  untransfected  or  uninfected  neighboring  cells  
[304–310], which is a promising tool for enhancing neuron transfection efficiency for gene therapy 
[311]. Although the PRV VP22 homologue, pUL49, is dispensable for virus growth in vitro and had no 
neuroinvasion  defects  in  vivo  [312],  HSV-1  VP22  is  important  for  efficient  viral  spread  both  in 
cultured cells and mouse cornea, reducing HSV titers by one log in cultured cells [313]. 
There are other herpesvirus proteins known to affect the microtubule cytoskeleton. One of them is 
ICP0, which is a ring finger E3 ligase that regulates virus mRNA synthesis and the balance between 
replication and latency of the virus. In transfected or HSV-1 infected Vero cells, ICP0 translocates into 
the cytoplasm from the nucleus, where it bundles microtubules and dismantles them [314]. Another 
viral protein, pUL25, interacts with tubulin and ankyrin 2 (neuronal microtubule-associated protein) in 
a yeast-two-hybrid assay [315]. Additionally, pUL21, a binding partner for pUL16 and an important 
component of egress mechanism, binds to microtubules and causes the appearance of long processes 
when overexpressed in cultured cells [316]. Further studies of these HSV proteins in vivo could give 
insight on viral regulation of neuronal microtubule cytoskeleton.  
3. Concluding Remarks  
The neuroinvasive properties of the Simplexviruses and Varicelloviruses are unlike those of any 
other known viruses. While many viruses can invade the nervous system sporadically (i.e., poliovirus) 
or  following  intramuscular  puncture  (i.e.,  rabies),  neuroinvasive  herpesviruses  are  unique  in  their 
combined abilities  to invade  the nervous  system routinely through undamaged  tissue  and regulate 
retrograde and anterograde trafficking effectively to enter and exit the nervous system. Chief among 
the tactics used by these viruses to effect this infectious cycle are numerous interactions with the 
cytoskeleton in two types of polarized cells: epithelia and neurons. The radically different cytoskeletal 
architectures of these cells are effectively navigated by these viruses by mechanisms that are only 
beginning to be unraveled. For a virus to spread from the apical surface of an epithelium to the nuclear 
pores of a neuron likely requires several reversals in microtubule transport direction along the way, 
which helps to explain why other viruses do not share the neuroinvasive program encoded by the 
herpesviruses. The complexity of the infectious cycle is matched by the complexity of these viruses. 
But  with  this  complexity  comes  opportunities  for  the  development  of  novel  antiviral  targets  and 
scientific exploit. We have a lot to learn from a virus that can deliver genes to the nervous system 
merely by being placed on the skin, and it will only be a matter of time before we fully tame it. In the 
meantime, we can look forward to the continued identification and development of new classes of 
antivirals that exploit viral-cytoskeleton interactions [317]. Viruses 2011, 3                         
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